-
公开(公告)号:US07956041B2
公开(公告)日:2011-06-07
申请号:US10972743
申请日:2004-10-26
申请人: Katsumi Maezono , Nozomu Ishida , Koji Ohsumi , Hiroyuki Matsueda , Toshihiro Hatanaka , Ryusuke Hirama , Yoko Kageyama , Nobuo Kondo
发明人: Katsumi Maezono , Nozomu Ishida , Koji Ohsumi , Hiroyuki Matsueda , Toshihiro Hatanaka , Ryusuke Hirama , Yoko Kageyama , Nobuo Kondo
CPC分类号: A61K31/426 , A61K31/155 , A61K31/175 , A61K31/197 , A61K31/4439 , A61K31/4453 , A61K31/64 , A61K31/7056 , A61K38/28 , A61K45/06 , A61K2300/00
摘要: The invention provides a prophylactic and therapeutic agent of diabetes mellitus, including a combination of an inhibitor of renal glucose reabsorption and a hypoglycemic agent. In accordance with the invention, hyperglycemia after meals, between meals and during fasting can be ameliorated. More specifically, in accordance with the invention, a therapeutic effect of diabetes mellitus as never been obtained by the hypoglycemic agents of the related art can be achieved.
摘要翻译: 本发明提供糖尿病的预防和治疗剂,包括肾葡萄糖再吸收抑制剂和降血糖药的组合。 根据本发明,可以改善膳食后,膳食间和禁食期间的高血糖。 更具体地,根据本发明,可以实现由相关领域的降血糖剂从未获得的糖尿病的治疗效果。
-
公开(公告)号:US07256209B2
公开(公告)日:2007-08-14
申请号:US11567039
申请日:2006-12-05
申请人: Koji Ohsumi , Takashi Umemura , Hiroyuki Matsueda , Toshihiro Hatanaka , Akiko Onuki , Katsumi Maezono , Yoko Kageyama , Nobuo Kondo
发明人: Koji Ohsumi , Takashi Umemura , Hiroyuki Matsueda , Toshihiro Hatanaka , Akiko Onuki , Katsumi Maezono , Yoko Kageyama , Nobuo Kondo
IPC分类号: A61K31/415 , C07D231/12
CPC分类号: A61K31/7056 , C07H17/02 , Y10S514/866
摘要: The present invention provides pyrazole-O-glycoside derivatives represented by the following formulae, used as a diabetic medicine
-
公开(公告)号:US07247616B2
公开(公告)日:2007-07-24
申请号:US11255937
申请日:2005-10-24
申请人: Koji Ohsumi , Takashi Umemura , Hiroyuki Matsueda , Toshihiro Hatanaka , Akiko Onuki , Katsumi Maezono , Yoko Kageyama , Nobuo Kondo
发明人: Koji Ohsumi , Takashi Umemura , Hiroyuki Matsueda , Toshihiro Hatanaka , Akiko Onuki , Katsumi Maezono , Yoko Kageyama , Nobuo Kondo
IPC分类号: A61K31/70 , A61K31/7028 , A61K31/7042 , C07H17/02
CPC分类号: A61K31/7056 , C07H17/02 , Y10S514/866
摘要: The present invention provides pyrazole-O-glycoside derivatives represented by the following formulae, used as a diabetic medicine
摘要翻译: 本发明提供用作糖尿病药的由下式表示的吡唑-O-糖苷衍生物
-
公开(公告)号:US07015201B2
公开(公告)日:2006-03-21
申请号:US10936535
申请日:2004-09-09
申请人: Koji Ohsumi , Takashi Umemura , Hiroyuki Matsueda , Toshihiro Hatanaka , Akiko Onuki , Katsumi Maezono , Yoko Kageyama , Nobuo Kondo
发明人: Koji Ohsumi , Takashi Umemura , Hiroyuki Matsueda , Toshihiro Hatanaka , Akiko Onuki , Katsumi Maezono , Yoko Kageyama , Nobuo Kondo
IPC分类号: A61K31/70 , A61K31/7028 , A61K31/7042 , C07H17/02
CPC分类号: A61K31/7056 , C07H17/02 , Y10S514/866
摘要: The present invention provides pyrazole-O-glycoside derivatives represented by the following formulae, used as a diabetic medicine.
摘要翻译: 本发明提供用作糖尿病药的由下式表示的吡唑-O-糖苷衍生物。
-
公开(公告)号:US20050143424A1
公开(公告)日:2005-06-30
申请号:US10972743
申请日:2004-10-26
申请人: Katsumi Maezono , Nozomu Ishida , Koji Ohsumi , Hiroyuki Matsueda , Toshihiro Hatanaka , Ryusuke Hirama , Yoko Kageyama , Nobuo Kondo
发明人: Katsumi Maezono , Nozomu Ishida , Koji Ohsumi , Hiroyuki Matsueda , Toshihiro Hatanaka , Ryusuke Hirama , Yoko Kageyama , Nobuo Kondo
IPC分类号: A61K31/155 , A61K31/175 , A61K31/197 , A61K31/426 , A61K31/4439 , A61K31/4453 , A61K31/64 , A61K31/7056 , A61K38/28 , A61K45/06
CPC分类号: A61K31/426 , A61K31/155 , A61K31/175 , A61K31/197 , A61K31/4439 , A61K31/4453 , A61K31/64 , A61K31/7056 , A61K38/28 , A61K45/06 , A61K2300/00
摘要: The invention provides a prophylactic and therapeutic agent of diabetes mellitus, including a combination of an inhibitor of renal glucose reabsorption and a hypoglycemic agent. In accordance with the invention, hyperglycemia after meals, between meals and during fasting can be ameliorated. More specifically, in accordance with the invention, a therapeutic effect of diabetes mellitus as never been obtained by the hypoglycemic agents of the related art can be achieved.
摘要翻译: 本发明提供糖尿病的预防和治疗剂,包括肾葡萄糖再吸收抑制剂和降血糖药的组合。 根据本发明,可以改善膳食后,膳食间和禁食期间的高血糖。 更具体地,根据本发明,可以实现由相关领域的降血糖剂从未获得的糖尿病的治疗效果。
-
公开(公告)号:US06784315B2
公开(公告)日:2004-08-31
申请号:US10243649
申请日:2002-09-16
IPC分类号: C07C23305
CPC分类号: A61K31/167 , C07C231/24 , C07C237/08 , C07C237/04
摘要: A Type IV crystal of (Z)-N-[2-methoxy-5-[2-(3,4,5-trimethoxyphenyl)vinyl]phenyl]-L-serinamide hydrochloride, which can be produced by crystallization using a solvent containing water at 2% by weight at the maximum and which has a X ray powder diffraction pattern containing peaks at least at 13.4°, 18.7°, 19.4°, and 22.5° (2&thgr;), is provided. This compound is useful as an effective ingredient for a carcinostatic agent. The crystal of the present invention has excellent properties desirable from the standpoint of the production of medicinal products, i.e., reduced water adsorption and extremely high stability to water. Also provided are a method for producing the Type IV crystal thereof and a method for use of the crystal.
摘要翻译: (Z)-N- [2-甲氧基-5- [2-(3,4,5-三甲氧基苯基)乙烯基]苯基] -L-丝氨酰胺盐酸盐的IV型晶体,其可以通过使用含有 提供最大为2重量%的水,并且其具有含有至少13.4°,18.7°,19.4°和22.5°(2θ)的峰的X射线粉末衍射图。 该化合物可用作制癌剂的有效成分。 本发明的结晶从药物生产的观点出发,具有优异的性能,即减少水分吸附和极高的水稳定性。 还提供了其IV型晶体的制造方法和使用该晶体的方法。
-
公开(公告)号:US07326701B2
公开(公告)日:2008-02-05
申请号:US11398675
申请日:2006-04-06
申请人: Yukio Iino , Takao Ikenoue , Nobuo Kondo , Hiroyuki Matsueda , Toshihiro Hatanaka , Ryusuke Hirama , Yoko Masuzawa , Fumio Ohta , Akiyo Yamazaki , Seiji Niwa , Takashi Yamamoto
发明人: Yukio Iino , Takao Ikenoue , Nobuo Kondo , Hiroyuki Matsueda , Toshihiro Hatanaka , Ryusuke Hirama , Yoko Masuzawa , Fumio Ohta , Akiyo Yamazaki , Seiji Niwa , Takashi Yamamoto
IPC分类号: C07D487/04 , A61K31/5517 , A61P3/10
CPC分类号: C07D487/04 , A61K31/5517 , A61K31/554 , C07D243/10 , C07D513/04
摘要: An agent for increasing the sugar-transporting capacity and an agent for preventing and/or treating diabetes, diabetic peripheral neuropathy, diabetic nephropathy, diabetic retinopathy, diabetic macroangiopathy, impaired glucose tolerance or adiposis, which contains a lactam compound or a pharmaceutically acceptable salt thereof as the active ingredient.
摘要翻译: 含有内酰胺化合物或其药学上可接受的盐的增加糖输送能力的药剂和用于预防和/或治疗糖尿病,糖尿病性周围神经病变,糖尿病性肾病,糖尿病性视网膜病变,糖尿病性大血管病变,葡萄糖耐量异常或脂肪变性的药剂 作为活性成分。
-
公开(公告)号:US20070270479A1
公开(公告)日:2007-11-22
申请号:US11774102
申请日:2007-07-06
申请人: Koji OHSUMI , Takashi Umemura , Hiroyuki Matsueda , Toshihiro Hatanaka , Akiko Onuki , Katsumi Maezono , Yoko Kageyama , Nobuo Kondo
发明人: Koji OHSUMI , Takashi Umemura , Hiroyuki Matsueda , Toshihiro Hatanaka , Akiko Onuki , Katsumi Maezono , Yoko Kageyama , Nobuo Kondo
IPC分类号: A61K31/4155 , A61P3/10 , C07D231/14
CPC分类号: A61K31/7056 , C07H17/02 , Y10S514/866
摘要: The present invention provides pyrazole-O-glycoside derivatives represented by the following formulae, used as a diabetic medicine.
-
公开(公告)号:US20060058244A1
公开(公告)日:2006-03-16
申请号:US11255937
申请日:2005-10-24
申请人: Koji Ohsumi , Takashi Umemura , Hiroyuki Matsueda , Toshihiro Hatanaka , Akiko Onuki , Katsumi Maezono , Yoko Kageyama , Nobuo Kondo
发明人: Koji Ohsumi , Takashi Umemura , Hiroyuki Matsueda , Toshihiro Hatanaka , Akiko Onuki , Katsumi Maezono , Yoko Kageyama , Nobuo Kondo
IPC分类号: A61K31/7052 , C07H17/02
CPC分类号: A61K31/7056 , C07H17/02 , Y10S514/866
摘要: The present invention provides pyrazole-O-glycoside derivatives represented by the following formulae, used as a diabetic medicine.
摘要翻译: 本发明提供用作糖尿病药的由下式表示的吡唑-O-糖苷衍生物。
-
公开(公告)号:US20120065266A1
公开(公告)日:2012-03-15
申请号:US13230958
申请日:2011-09-13
申请人: Shinichi Fujita , Yoshiaki Hanzawa , Noriko Yasa , Hiroyuki Matsueda , Hideaki Kihara , Motoyasu Kusano , Osamu Kawamura , Yasuyuki Shimoyama , Hiroko Hosaka , Hiroaki Zai , Atsuto Nagoshi
发明人: Shinichi Fujita , Yoshiaki Hanzawa , Noriko Yasa , Hiroyuki Matsueda , Hideaki Kihara , Motoyasu Kusano , Osamu Kawamura , Yasuyuki Shimoyama , Hiroko Hosaka , Hiroaki Zai , Atsuto Nagoshi
IPC分类号: A61K31/198 , A61P1/00
CPC分类号: A61K9/1652 , A61K31/198 , A61K2300/00
摘要: The present invention provides an oral composition which can more effectively prevent or improve functional gastrointestinal disorders, particularly upper gastrointestinal dysfunction, specifically functional dyspepsia, and is highly safe and suitable for long-term ingestion.The oral composition of the present invention contains sodium glutamate and arginine hydrochloride at a molar ratio of 1:1. The aforementioned composition can be provided as an agent for the prophylaxis or improvement of functional gastrointestinal disorder, and can also be provided in a food or drink.
摘要翻译: 本发明提供一种口服组合物,其可以更有效地预防或改善功能性胃肠道疾病,特别是上消化道功能障碍,特别是功能性消化不良,并且是高度安全的并且适合于长期摄入。 本发明的口服组合物以1:1的摩尔比含有谷氨酸钠和精氨酸盐酸盐。 可以提供上述组合物作为预防或改善功能性胃肠道疾病的药剂,也可以提供在食品或饮料中。
-
-
-
-
-
-
-
-
-